Reversible segmental cerebral arterial vasospasm and cerebral infarction: Possible association with excessive use of sumatriptan and Midrin

Archives of Neurology

Volumn 55, Issue 5, 1998, Pages 712-714

  Meschia, James F ^a   Malkoff, Marc D ^b   Biller, José ^b  

^a MAYO CLINIC   (United States)

^b INDIANA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ISOMETHEPTENE MUCATE; PETHIDINE; PREDNISONE; SUMATRIPTAN;

ADULT; ARTICLE; BLOOD VESSEL DIAMETER; BRAIN ARTERY; BRAIN INFARCTION; BRAIN VASOSPASM; CASE REPORT; DIGITAL SUBTRACTION ANGIOGRAPHY; DRUG EFFECT; HUMAN; MALE; MIGRAINE; PRIORITY JOURNAL;

ACETAMINOPHEN; ADULT; ANTIPYRINE; CEREBRAL INFARCTION; CHLORAL HYDRATE; DRUG COMBINATIONS; DRUG THERAPY, COMBINATION; HUMANS; ISCHEMIC ATTACK, TRANSIENT; MALE; METHYLAMINES; NICARDIPINE; OCCIPITAL LOBE; SUMATRIPTAN; VASOCONSTRICTOR AGENTS; VASODILATOR AGENTS;

EID: 0031955706     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.55.5.712     Document Type: Article

References (17)

1. Luman W, Gray RS. Adverse reactions associated with sumatriptan. Lancet. 1993; 341:1091-1092.
2. Cavazos JE, Caress JB, Chilukuri VR. Sumatriptan-induced stroke in sagittal sinus thrombosis. Lancet. 1994;343:1105-1106.
3. Jayamaha JEL, Street MK. Fatal cerebellar infarction in a migraine sufferer whilst receiving sumatriptan. Intensive Care Med. 1995;21:82-83.
4. Mueller L, Gallagher RM, Ciervo CA. Vasospasm-induced myocardial infarction with sumatriptan. Headache. 1996;36:329-331.
5. Ottervanger JP, Stricker BHC. Cardiovascular adverse reactions to sumatriptan: cause for concern? CNS Drugs. 1996;3:90-98.
6. O'Connor P, Gladstone P. Oral sumatriptan-associated transmural myocardial infarction. Neurology. 1995;45:2274-2276.
7. Kelly KM. Cardiac arrest following use of sumatriptan. Neurology. 1995;45:1211-1213.
8. Connor HE, Feniuk W, Humphrey PPA. Characterization of 5-HT receptors mediating contraction of canine and primate basilar artery by use of GR43175, a selective 5-HT1-like receptor agonist. Br J Pharmacol. 1989;96:379-387.
9. Parsons AA, Whalley ET. Evidence for the presence of 5-HT1-like receptors in rabbit isolated basilar arteries. Eur J Pharmacol. 1989;174:189-196.
10. Parsons AA, Whalley ET, Feniuk W, Connor HE, Humphrey PPA. 5-HT1-like receptors mediate 5-hydroxytryptamine-induced contraction of human basilar artery. Br J Pharmacol. 1989;96:434-449.
11. Parsons AA. 5-HT receptors in human and animal cerebrovasculature. Trends Pharmacol Sci. 1991;12:310-315.
12. Call GK, Fleming MC, Sealfon S, Levine H, Kistler JP, Fisher CM. Reversible cerebral segmental vasoconstriction. Stroke. 1988;19:1159-1170.
13. Raroque HG Jr, Tesfa G, Purdy P. Postpartum cerebral angiopathy: is there a role for sympathomimetic drugs? Stroke. 1993;24:2108-2110.
14. Grennan TO, Grossman RI, Goldberg HI. Cerebral vasculitis: MR imaging and angiographic correlation. Radiology. 1992;182:65-72.
15. Duna GF, Calabrese LH. Limitations of invasive modalities in the diagnosis of primary angiitis of the central nervous system. J Rheumatol. 1995;22:662-667.
16. Calabrese LH, Furlan AG, Gragg LA, Ropos TJ. Primary angiitis of the central nervous system: diagnostic criteria and clinical approach. Cleve Clin J Med. 1992; 59:293-306.
17. Haley EC, Kassell NF, Torner JC, et al. A randomized controlled trial of high-dose intravenous nicardipine in aneurysmal subarachnoid hemorrhage. J Neurosurg. 1993;78:537-547.